Both ANGPTL3 and apoC-III inhibit lipoprotein lipase (LPL), the enzyme responsible for hydrolyzing triglycerides in TRLs, leading to increased circulating TRLs and remnant cholesterol, which promote atherosclerosis [68]. The gene discussed is APOC3; the disease is atherosclerosis.